Dinaciclib
Dinaciclib is a new-type and effective CDK inhibitor for CDK2/5/1/9 (IC50: 1 nM/1 nM/3 nM/4 nM) with potential antineoplastic activity.
| Catalog Number | T1912 |
| Alternative Name(s) | SCH 727965 , PS-095760 |
| Research Area | Cell Cycle/Checkpoint|||Apoptosis |
| Molecular Formula | C21H28N6O2 |
| CAS# | 779353-01-4 |
| Purity | 99.73% |
| SMILES | CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N1CCCC[C@H]1CCO |
| Size | 50 mg |
| Supplier Page | https://www.targetmol.com/compound/Dinaciclib |
| Additional Information | https://www.targetmol.com/datasheet/T1912 |